EL7.AI
StocksMediumUpdated×2•Originally published 27 October 2026•Updated 28 October 2026•
4 min read

Hydrofarm Settles Loan of About $109 Million With Shares and Warrants, Raises $8.3 Million

Key Facts

1Loan principal outstanding was about $109 million on September 30, before it was terminated in the October 27 settlement.
2The company issued 27.5 million convertible preferred shares, with warrants to purchase up to 27.5 million common shares at $0.78.
3The offering raised $8.3 million in gross proceeds before expenses when it closed on October 27.
4Second-quarter sales fell 40.9% to $23.2 million from $39.2 million a year earlier.

Hydrofarm announced on October 27 that it had completed the settlement of a secured loan with principal outstanding of about $109 million as of September 30, alongside a share offering that raised $8.3 million in gross proceeds before expenses. The company said in its filing that the loan and its documents were terminated and the obligations under the credit agreement discharged after the conditions of the payoff letter were met. The consideration allocated to lenders was converted into equity instruments and warrants, while the cash offering proceeds were allocated for general corporate purposes. The value of the loan extinguished therefore does not represent cash received by the company; cash proceeds from the offering totaled $8.3 million before expenses. The settlement follows quarterly results showing lower sales and liquidity pressures, marking a shift in the company’s liabilities and ownership structure.

The debt settlement included the issuance to lenders of 27.5 million non-voting convertible preferred shares, along with warrants to purchase up to 27.5 million common shares at an exercise price of $0.78 per share. The lenders’ warrants may not be exercised until shareholders approve them. These instruments represent a potential increase in the number of shares outstanding if converted or exercised, which could dilute existing shareholders’ stakes. The company closed the registered direct offering and private placement on October 27, raising $8.3 million in gross proceeds before expenses. It said the funds would be used for general corporate purposes, while the loan was addressed through preferred shares and warrants.

Second-quarter results show the contraction in activity that preceded the debt restructuring: sales fell 40.9% to $23.2 million from $39.2 million in the year-earlier period. Hydrofarm attributed the decline to lower volume and a less favorable mix of products sold, mainly related to excess supply in the sector and the discontinuation of distribution for certain brands. Reported gross margin rose to 11.3% of sales from 7.1% a year earlier, but gross profit fell to $2.6 million from $2.8 million. The company said a higher share of sales from its proprietary brands was the main contributor to the margin improvement. Adjusted gross margin, a non-GAAP measure, was 20.0% versus 19.2%, while adjusted gross profit declined to $4.6 million from $7.5 million.

Selling, general and administrative expenses fell to $10.1 million in the second quarter from $16.1 million a year earlier, and Hydrofarm said the decline in these expenses was the main reason its net loss narrowed. Adjusted expenses in this category also fell 35.7% year over year. The chief executive said the company posted its highest quarterly mix of proprietary-brand sales in its history, and that year-over-year expense reductions continued for the sixteenth consecutive quarter. Revenue declines, meanwhile, remained evident in cash flows, with both operating cash flow and free cash flow nearing breakeven during the quarter. The comparable figures were $1.7 million and $1.4 million, respectively, in the year-earlier quarter.

The company ended the quarter on June 30 with $6.2 million in cash and $0.5 million in restricted cash, against $114.4 million of term-loan principal, $7.6 million in finance lease liabilities and $0.1 million in other debt. On February 4, it deferred an interest payment of about $2.8 million on the loan, triggering an event of default and the classification of the loan as current debt. The forbearance period was later extended under an agreement with lenders through August 31, 2026. In an earlier effort to reduce debt, Hydrofarm completed the sale of Aurora Peat Products in Canada on July 31 for $16 million, including a $5 million promissory note. The company said the sale proceeds were allocated to reduce loan debt and accrued interest.

Hydrofarm said its pro forma balance sheet after the transactions exceeds Nasdaq’s $2.5 million minimum shareholders’ equity requirement and that it believes it has regained compliance with the requirement. The company remains subject to review and monitoring by Nasdaq’s panel, including the minimum bid price rule. Its shares closed at $0.845 on October 26 and at $0.789 on October 27, the day of the announcement; the closing price does not establish the timing of the share move relative to the news during the session. For the first half of the year, the company recorded sales of $51.735 million versus $79.779 million in the corresponding period of 2025. These figures place the debt settlement in the context of a business facing declining revenue, while the impact of the equity instruments depends on conversion and shareholder approval, and Nasdaq’s review on continued monitoring of the company’s compliance.

Open on chart